36 related articles for article (PubMed ID: 17509076)
1. N-glycan on N262 of FGFR3 regulates the intracellular localization and phosphorylation of the receptor.
Hashimoto U; Fujitani N; Uehara Y; Okamoto H; Saitou A; Ito F; Ariki S; Shiratsuchi A; Hasegawa Y; Takahashi M
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130565. PubMed ID: 38244702
[TBL] [Abstract][Full Text] [Related]
2. The respiratory elastance ratio in thanatophoric dysplasia: A case report.
Aoki K; Kurosawa H; Shirasawa A; Shiomi Y; Seino Y
Pediatr Int; 2023; 65(1):e15534. PubMed ID: 36965046
[No Abstract] [Full Text] [Related]
3. Exploring the Micro-Mosaic Landscape of
Striedner Y; Arbeithuber B; Moura S; Nowak E; Reinhardt R; Muresan L; Salazar R; Ebner T; Tiemann-Boege I
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397181
[TBL] [Abstract][Full Text] [Related]
4. Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling.
Szybowska P; Kostas M; Wesche J; Haugsten EM; Wiedlocha A
Cells; 2021 May; 10(6):. PubMed ID: 34071546
[TBL] [Abstract][Full Text] [Related]
5. IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking.
Sivanesan D; Beauchamp C; Quinou C; Lee J; Lesage S; Chemtob S; Rioux JD; Michnick SW
J Biol Chem; 2016 Apr; 291(16):8673-85. PubMed ID: 26887945
[TBL] [Abstract][Full Text] [Related]
6. A Genetic-Pathophysiological Framework for Craniosynostosis.
Twigg SR; Wilkie AO
Am J Hum Genet; 2015 Sep; 97(3):359-77. PubMed ID: 26340332
[TBL] [Abstract][Full Text] [Related]
7. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
8. Effect of thanatophoric dysplasia type I mutations on FGFR3 dimerization.
Del Piccolo N; Placone J; Hristova K
Biophys J; 2015 Jan; 108(2):272-8. PubMed ID: 25606676
[TBL] [Abstract][Full Text] [Related]
9. Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies.
Bocharov EV; Lesovoy DM; Goncharuk SA; Goncharuk MV; Hristova K; Arseniev AS
Structure; 2013 Nov; 21(11):2087-93. PubMed ID: 24120763
[TBL] [Abstract][Full Text] [Related]
10. Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3.
Chen F; Sarabipour S; Hristova K
PLoS One; 2013; 8(2):e56521. PubMed ID: 23437153
[TBL] [Abstract][Full Text] [Related]
11. Effect of the G375C and G346E achondroplasia mutations on FGFR3 activation.
He L; Serrano C; Niphadkar N; Shobnam N; Hristova K
PLoS One; 2012; 7(4):e34808. PubMed ID: 22529939
[TBL] [Abstract][Full Text] [Related]
12. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.
Foldynova-Trantirkova S; Wilcox WR; Krejci P
Hum Mutat; 2012 Jan; 33(1):29-41. PubMed ID: 22045636
[TBL] [Abstract][Full Text] [Related]
13. Physical-chemical principles underlying RTK activation, and their implications for human disease.
He L; Hristova K
Biochim Biophys Acta; 2012 Apr; 1818(4):995-1005. PubMed ID: 21840295
[TBL] [Abstract][Full Text] [Related]
14. The A391E mutation enhances FGFR3 activation in the absence of ligand.
Chen F; Degnin C; Laederich M; Horton WA; Hristova K
Biochim Biophys Acta; 2011 Aug; 1808(8):2045-50. PubMed ID: 21536014
[TBL] [Abstract][Full Text] [Related]
15. Physical basis behind achondroplasia, the most common form of human dwarfism.
He L; Horton W; Hristova K
J Biol Chem; 2010 Sep; 285(39):30103-14. PubMed ID: 20624921
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.
Li E; Hristova K
Cell Adh Migr; 2010; 4(2):249-54. PubMed ID: 20168077
[TBL] [Abstract][Full Text] [Related]
17. Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.
di Martino E; L'Hôte CG; Kennedy W; Tomlinson DC; Knowles MA
Oncogene; 2009 Dec; 28(48):4306-16. PubMed ID: 19749790
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.
Haugsten EM; Malecki J; Bjørklund SM; Olsnes S; Wesche J
Mol Biol Cell; 2008 Aug; 19(8):3390-403. PubMed ID: 18480409
[TBL] [Abstract][Full Text] [Related]
19. The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor.
Bonaventure J; Horne WC; Baron R
FEBS J; 2007 Jun; 274(12):3078-93. PubMed ID: 17509076
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
